Choosing CD marker antibodies for immunophenotyping: what a cd19 antibody, a cd45 antibody, a cd44 antibody, a cd3e antibody, a cd8 antibody, a cd14 antibody, a cd34 antibody, a cd68 antibody, a cd94 antibody, a cd163 antibody and a cd9 antibody each identify, why the clone rather than the target decides the panel, and the titration every one of them needs

Choosing the reagent for the marker

1. Buy the clone, not the CD number. The antigen is defined by the CD nomenclature and the reagent is defined by the clone. Published panels cite clones for that reason, and substituting a different clone against the same antigen is a change that has to be re-titrated and re-validated rather than assumed equivalent.
2. Know what each marker actually resolves. CD45 separates leucocytes from everything else and is the usual backbone of a panel. CD19 marks B cells, CD3e marks T cells, CD14 marks monocytes and CD68 marks macrophages, largely intracellularly. CD44 is broadly expressed and is a state marker rather than a lineage one, which is why it needs a quantitative rather than a positive or negative reading.
3. Match the format to the assay. A clone selected against native surface protein for flow cytometry may not work on a fixed section, and an antibody validated for immunohistochemistry may not stain live cells. Read the evidence per application rather than the application list, and buy against the assay you will run.
4. Titrate every conjugate on your own sample. The datasheet dilution came from somebody else's cells and buffer. Run a dilution series and choose the concentration giving the best separation between positive and negative, which is frequently several times more dilute than recommended and always cheaper.
5. Assign brightness against abundance across the panel. Put the brightest fluorochromes on the least abundant antigens. A very bright conjugate on an abundant marker like CD45 spreads into neighbouring detectors and costs resolution on the markers that needed it.

Fixation and permeabilisation change the answer

Surface markers are stained on live or lightly fixed cells; an intracellular marker such as CD68 needs permeabilisation, and the permeabilisation that works for a cytoplasmic protein is not the one that works for a nuclear one. Choose the buffer system for the hardest marker in the panel.

Test the surface markers under the permeabilisation conditions the panel will use. Several surface epitopes are damaged by the harsher permeabilisation reagents, and the loss looks like poor staining rather than a protocol problem.

Controls that make a gate defensible

A viability dye, an unstained control, single stained compensation controls on the same carrier as the experiment, and a fluorescence minus one control for any marker whose gate is not obvious. The last of those is the one most often skipped and the one that decides where a boundary sits.

For a study running over months, a frozen reference sample run with every batch is what separates instrument and reagent drift from biology.

Recording the panel so it can be rebuilt

Marker, clone, conjugate, supplier, catalogue number, lot and the titrated volume per test. A panel recorded as a list of colours cannot be reproduced when a reagent is discontinued, which happens more often than people plan for.

Keep the titration data with the panel record. When a new lot arrives, the previous titration curve is the fastest way to see whether anything has moved.

Common questions

Are two antibodies against the same CD antigen interchangeable?

No. They may recognise different epitopes, tolerate fixation differently and separate populations differently. The clone is the product, which is why published panels cite clones rather than CD numbers alone.

What does a cd45 antibody do in a panel?

It separates leucocytes from debris, red cells and non-haematopoietic material, which is why it is the usual backbone marker. Getting it right makes every other gate in the panel cleaner.

Why is CD44 harder to interpret than a lineage marker?

Because it is broadly expressed and its level changes with cell state rather than identity. It should be read as a quantitative measure against a control, not as a positive or negative gate.

Do I need to re-titrate when the lot changes?

Yes, and it takes an afternoon. Conjugate lot changes shift the optimal concentration, and a panel that drifts across a study is usually a lot change nobody re-titrated.

Browse by service class

• Compare Gene synthesis on advertised prices